Schering Plough announces substantial Q4 loss

Pharmaceutical giant Schering-Plough said today it had made a loss of $181m (€143.9m) in the fourth quarter, against profits of $313m (€248.9m), a year earlier.

The loss was led by a decline in sales and special charges of $229m (€182m) related to a voluntary retirement program.